Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Cefuroxime Axetil. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC4 | O15439 | 2/20 | 1.00 |
| ▸ | PDE4A | P27815 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 9/20 | 0.78 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.78 |
| ▸ | NR1I2 | O75469 | 4/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.78 |
| ▸ | PGR | P06401 | 1/20 | 0.78 |
| ▸ | TSHR | P16473 | 1/20 | 0.78 |
| ▸ | MAPT | P10636 | 7/20 | 0.76 |
| ▸ | CTDSP1 | Q9GZU7 | 3/20 | 0.76 |
| ▸ | POLB | P06746 | 2/20 | 0.76 |
| ▸ | PKM | P14618 | 2/20 | 0.76 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.76 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.54 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.54 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.50 |
| ▸ | SLC22A8 | Q8TCC7 | 2/20 | 0.50 |
| ▸ | SLC22A11 | Q9NSA0 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cefuroxime Axetil SCHEMBL6859269 | 1.00 | ABCC4 (1.00) | ABCC4PDE4ATDP1HSD17B10NR1I2 | |
| Cefuroxime Axetil SCHEMBL41099 | 1.00 | ABCC4 (1.00) | ABCC4PDE4ATDP1HSD17B10NR1I2 | |
| Cefuroxime Axetil SCHEMBL7767287 | 1.00 | ABCC4 (1.00) | ABCC4PDE4ATDP1HSD17B10NR1I2 | |
| Cefuroxime Axetil SCHEMBL13575811 | 1.00 | ABCC4 (1.00) | ABCC4PDE4ATDP1HSD17B10NR1I2 | |
| Cefuroxime Axetil SCHEMBL721709 | 1.00 | ABCC4 (1.00) | ABCC4PDE4ATDP1HSD17B10NR1I2 | |
| Cefuroxime Axetil SCHEMBL10556419 | 1.00 | ABCC4 (1.00) | ABCC4PDE4ATDP1HSD17B10NR1I2 | |
| Cefuroxime Axetil SCHEMBL2221553 | 0.97 | ABCC4 (0.95) | ABCC4PDE4ATDP1HSD17B10NR1I2 | |
| Cefuroxime Axetil SCHEMBL18048098 | 0.97 | ABCC4 (0.95) | ABCC4PDE4ATDP1HSD17B10NR1I2 | |
| Cefuroxime Axetil SCHEMBL2322261 | 0.97 | ABCC4 (0.94) | ABCC4PDE4ATDP1HSD17B10NR1I2 | |
| Cefuroxime Axetil SCHEMBL2322632 | 0.92 | ABCC4 (0.84) | ABCC4PDE4ATDP1HSD17B10NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2374 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240282425-A1 | AUTHENTICATION METHODS AND SYSTEMS FOR DISPENSED PRESCRIPTIONS | LOW GORDON KEITH (US) | 2024-08-22 | — | — | US | claimed |
| WO-2024155256-A1 | A NEW ANTIMICROBIAL SUSCEPTIBILITY TEST KIT AND IN-VITRO METHOD | SAKARYA ÜNİVERSİTESİ REKTÖRLÜĞÜ (TR) | 2024-07-25 | — | — | WO | claimed |
| US-20240122859-A1 | EXTENDED RELEASE MULTIPLE UNIT PELLET SYSTEM COMPOSITION AND ITS PROCESS FOR THE PREPARATION | NOKHA TRADING LLP (IN) | 2024-04-18 | — | — | US | claimed |
| WO-2022172225-A1 | EXTENDED RELEASE MULTIPLE UNIT PELLET SYSTEM COMPOSITION AND ITS PROCESS FOR THE PREPARATION | LYRUS LIFE SCIENCES PVT. LTD. (IN) | 2022-08-18 | — | — | WO | claimed |
| CN-113952313-A | Cefuroxime axetil capsule and preparation method thereof | 宁夏医科大学 | 2022-01-21 | — | — | CN | claimed |
| EP-2642992-B1 | COMPOUNDS AND THEIR USE | ALLECRA THERAPEUTICS GMBH (DE) | 2020-11-25 | — | — | EP | claimed |
| CN-110507658-A | Cefuroxime axetil pharmaceutical composition and preparation method thereof | SINOPHARM GROUP ZHIJUN SHENZHEN PHARMACY CO LTD | 2019-11-29 | — | — | CN | claimed |
| CN-110302170-A | A kind of cephalosporin analog antibiotic preparation and preparation method thereof | 北京新领先医药科技发展有限公司 | 2019-10-08 | — | — | CN | claimed |
| CN-110279665-A | A kind of combination tablet containing CEFUROXIME AXETIL | 周锡明 | 2019-09-27 | — | — | CN | claimed |
| CN-110214007-A | A kind of controlled release pharmaceutical compositions and preparation method thereof | 江苏恒瑞医药股份有限公司 | 2019-09-06 | — | — | CN | claimed |
| WO-2002005850-A2 | ENHANCEMENT OF THE ACTION OF ANTI-INFECTIVE AGENTS | PITMY INTERNATIONAL N.V. (AN) | 2002-01-24 | — | — | WO | claimed |
| US-6306391-B1 | COATING AGENT AND/OR MICROORGANISM TO PROVIDE A PROTECTIVE BARRIER; COMBINING AGENT AND MICROORGANISM INTO FORM OF CAPSULES OR TABLETS; BARRIER PROTECTS MICROOGRANISM FROM EFFECT OF ANTI-INFECTIVE AGENT | CADILA PHARMACEUTICALS, LTD. (IN) | 2001-10-23 | — | — | US | claimed |
| EP-1133298-A1 | COMPOSITIONS COMPRISING CEFUROXIME AXETIL | BIOCHEMIE Gesellschaft m.b.H. (AT) | 2001-09-19 | — | — | EP | claimed |
| US-6245735-B1 | CONJUGATE OF ANTIBIOTIC AND POLYPEPTIDE OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR OR LIPOPOLYSACCHARIDE BINDING FRAGMENT | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2001-06-12 | — | — | US | claimed |
| CN-1297352-A | Use of organophosphorous compounds for the therapeutic and prophylactic treatment of infections | HASSAN JOMAA (DE) | 2001-05-30 | — | — | CN | claimed |
| WO-2000030647-A1 | COMPOSITIONS COMPRISING CEFUROXIME AXETIL | BIOCHEMIE GESELLSCHAFT M.B.H. (AT) | 2000-06-02 | — | — | WO | claimed |
| EP-0998295-A1 | THE PROCESS FOR THE PREPARATION OF A STABLE FIXED DOSE PHARMACEUTICAL COMPOSITION OF ANTI INFECTIVE AGENT/AGENTS AND MICRO ORGANISMS AS ACTIVE INGREDIENTS | Cadila Pharmaceuticals (E.A.) Ltd. (KE) | 2000-05-10 | — | — | EP | claimed |
| WO-1999049875-A1 | THE PROCESS FOR THE PREPARATION OF A STABLE FIXED DOSE PHARMACEUTICAL COMPOSITION OF ANTI INFECTIVE AGENT/AGENTS AND MICRO ORGANISMS AS ACTIVE INGREDIENTS | CADILA PHARMACEUTICALS (E.A.) LTD. (IN) | 1999-10-07 | — | — | WO | claimed |
| US-4562181-A | INCREASED ABSORPTION VIA THE GASTROINTESTINAL TRACT, ALLOWING FOR ORAL OR RECTAL ADMINISTRATION | GLAXO GROUP LIMITED (GB) | 1985-12-31 | — | — | US | claimed |
| EP-0107276-A2 | Novel form of cefuroxime ester, process for its preparation and composition containing it | GLAXO GROUP LIMITED (GB) | 1984-05-02 | — | — | EP | claimed |